Source: Cancers. Unidade: FMRP
Subjects: MUTAÇÃO GENÉTICA, ACROMEGALIA, SOMATOSTATINA, BIOMARCADORES, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDEMBERG, Luiz Eduardo et al. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, v. 13, n. 19, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13194857. Acesso em: 18 nov. 2024.APA
Wildemberg, L. E., Henriques, D., Elias, P. C. L., Lima, C. H. de A., Musolino, N. R. de C., Camacho, A. H. S., et al. (2021). gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, 13( 19), 1-11. doi:10.3390/cancers13194857NLM
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13194857Vancouver
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13194857